An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Philip Morris International Inc. (PMI) will host a live webcast of its 2024 Annual Meeting of Shareholders on May 8, 2024, accessible at www.virtualshareholdermeeting.com/PM2024. The company is actively working towards a smoke-free future, investing in innovative smoke-free products. PMI acquired Swedish Match in 2022, expanding its presence in oral nicotine delivery. The smoke-free business accounted for 37% of PMI's total revenue in 2023.
Philip Morris International Inc. (PMI) terrà una trasmissione web in diretta della sua Assemblea Annuale degli Azionisti 2024 il 8 maggio 2024, accessibile su www.virtualshareholdermeeting.com/PM2024. L'azienda sta lavorando attivamente verso un futuro senza fumo, investendo in prodotti innovativi senza fumo. PMI ha acquisito Swedish Match nel 2022, espandendo la sua presenza nel settore della nicotina orale. Il business senza fumo ha rappresentato il 37% del totale dei ricavi di PMI nel 2023.
Philip Morris International Inc. (PMI) realizará una transmisión en vivo de su Reunión Anual de Accionistas de 2024 el 8 de mayo de 2024, disponible en www.virtualshareholdermeeting.com/PM2024. La compañía está trabajando activamente hacia un futuro sin humo, invirtiendo en productos innovadores sin humo. PMI adquirió Swedish Match en 2022, ampliando su presencia en la entrega de nicotina oral. El negocio sin humo representó el 37% de los ingresos totales de PMI en 2023.
Philip Morris International Inc.(PMI)은 2024년 5월 8일에 주주 총회를 웹캐스트로 생중계할 예정이며, www.virtualshareholdermeeting.com/PM2024에서 접근할 수 있습니다. 회사는 혁신적인 금연 제품에 투자하며 담배 없는 미래를 향해 적극적으로 노력하고 있습니다. PMI는 2022년에 스웨디시 매치를 인수하여 구강 니코틴 전달 분야에서 입지를 확대했습니다. 금연 사업은 2023년 PMI 총 수익의 37%를 차지했습니다.
Philip Morris International Inc. (PMI) organisera une webdiffusion en direct de son Assemblée annuelle des actionnaires de 2024 le 8 mai 2024, accessible sur www.virtualshareholdermeeting.com/PM2024. L'entreprise travaille activement à un avenir sans fumée, investissant dans des produits innovants sans fumée. PMI a acquis Swedish Match en 2022, élargissant sa présence dans la livraison de nicotine orale. Le secteur sans fumée a représenté 37 % du chiffre d'affaires total de PMI en 2023.
Philip Morris International Inc. (PMI) wird am 8. Mai 2024 eine Live-Webübertragung seiner jährlichen Hauptversammlung der Aktionäre über www.virtualshareholdermeeting.com/PM2024 anbieten. Das Unternehmen arbeitet aktiv an einer rauchfreien Zukunft und investiert in innovative rauchfreie Produkte. PMI hat 2022 Swedish Match übernommen und seine Präsenz im Bereich der oralen Nikotinabgabe ausgebaut. Das rauchfreie Geschäft machte 2023 37% des Gesamtumsatzes von PMI aus.
Positive
PMI actively investing in a smoke-free future and expanding its product portfolio beyond tobacco and nicotine.
Acquisition of Swedish Match in 2022 strengthened PMI's position in oral nicotine delivery.
The smoke-free business accounted for approximately 37% of PMI's total revenue in 2023.
Negative
None.
STAMFORD, CT--(BUSINESS WIRE)--
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of its 2024 Annual Meeting of Shareholders on Wednesday, May 8, 2024, at 9:00 a.m. ET. The meeting will be held in a virtual format only and can be accessed at www.virtualshareholdermeeting.com/PM2024. Presentation slides, script and an archived recording of the webcast will be available at the same link. The recording will be available for approximately one year from the date of the meeting.
During the meeting, André Calantzopoulos, Executive Chairman of the Board, and Jacek Olczak, Chief Executive Officer, will address shareholders and answer questions. Only shareholders of record with a valid 16-digit control number will be allowed to ask a question or make a comment.
The audio webcast may also be accessed on mobile devices by downloading PMI’s free Investor Relations App at www.pmi.com/irapp.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. As of December 31, 2023, PMI's smoke-free products were available for sale in 84 markets, and PMI estimates that approximately 33 million adults around the world use PMI's smoke-free products. Smoke-free business accounted for approximately 37% of PMI’s total full-year 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.
